Literature DB >> 26631573

Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; The role of NADPH oxidase 4.

Tiju Theccanat1, Jennifer L Philip2, Abdur M Razzaque2, Nicholas Ludmer1, Jinju Li1, Xianyao Xu2, Shahab A Akhter3.   

Abstract

Cardiac myocyte oxidative stress and apoptosis are considered important mechanisms for the development of heart failure (HF). Chronic HF is characterized by increased circulating catecholamines to augment cardiac output. Long-term stimulation of myocardial β-adrenergic receptors (β-ARs) is deleterious in cardiac myocytes, however, the potential mechanisms underlying increased cell death are unclear. We hypothesize that GRK2, a critical regulator of myocardial β-AR signaling, plays an important role in mediating cellular oxidative stress and apoptotic cell death in response to β-agonist stimulation. Stimulation of H9c2 cells with a non-selective β-agonist, isoproterenol (Iso) caused increased oxidative stress and apoptosis. There was also increased Nox4 expression, but no change in Nox2, the primary NADPH isoforms and major sources of ROS generation in cardiac myocytes. Adenoviral-mediated overexpression of GRK2 led to similar increases in ROS production and apoptosis as seen with Iso stimulation. These increases in oxidative stress were abolished by pre-treatment with the non-specific Nox inhibitor, apocynin, or siRNA knockdown of Nox4. Adenoviral-mediated expression of a GRK2 inhibitor prevented ROS production and apoptosis in response to Iso stimulation. β-Arrestins are signaling proteins that function downstream of GRK2 in β-AR uncoupling. Adenoviral-mediated overexpression of β-arrestins increased ROS production and Nox4 expression. Chronic β-agonist stimulation in mice increased Nox4 expression and apoptosis compared to PBS or AngII treatment. These data demonstrate that GRK2 may play an important role in regulating oxidative stress and apoptosis in cardiac myocytes and provides an additional novel mechanism for the beneficial effects of cardiac-targeted GRK2 inhibition to prevent the development of HF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  G protein-coupled receptor kinases; Heart failure; NADPH oxidase; Oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 26631573      PMCID: PMC4837949          DOI: 10.1016/j.cellsig.2015.11.013

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  30 in total

1.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

Review 2.  Structure and mechanism of the G protein-coupled receptor kinases.

Authors:  J Inglese; N J Freedman; W J Koch; R J Lefkowitz
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

Review 3.  Mechanism of action of beta-blocking agents in heart failure.

Authors:  M R Bristow
Journal:  Am J Cardiol       Date:  1997-12-04       Impact factor: 2.778

4.  Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats.

Authors:  L E Vinge; E Øie; Y Andersson; H K Grøgaard; G Andersen; H Attramadal
Journal:  Am J Physiol Heart Circ Physiol       Date:  2001-12       Impact factor: 4.733

5.  Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II.

Authors:  Wei-Zhong Zhu; Shi-Qiang Wang; Khalid Chakir; Dongmei Yang; Tong Zhang; Joan Heller Brown; Eric Devic; Brian K Kobilka; Heping Cheng; Rui-Ping Xiao
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

6.  Apoptosis in myocytes in end-stage heart failure.

Authors:  J Narula; N Haider; R Virmani; T G DiSalvo; F D Kolodgie; R J Hajjar; U Schmidt; M J Semigran; G W Dec; B A Khaw
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

7.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

8.  Adrenergic effects on the biology of the adult mammalian cardiocyte.

Authors:  D L Mann; R L Kent; B Parsons; G Cooper
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

9.  Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor.

Authors:  W J Koch; H A Rockman; P Samama; R A Hamilton; R A Bond; C A Milano; R J Lefkowitz
Journal:  Science       Date:  1995-06-02       Impact factor: 47.728

10.  Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice.

Authors:  H A Rockman; D J Choi; S A Akhter; M Jaber; B Giros; R J Lefkowitz; M G Caron; W J Koch
Journal:  J Biol Chem       Date:  1998-07-17       Impact factor: 5.157

View more
  19 in total

1.  Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat.

Authors:  Nikhat Saleem; Anamika Prasad; Shyamal K Goswami
Journal:  Mol Cell Biochem       Date:  2017-12-18       Impact factor: 3.396

2.  Activation of adrenergic receptor in H9c2 cardiac myoblasts co-stimulates Nox2 and the derived ROS mediate the downstream responses.

Authors:  Nikhat Saleem; Shyamal K Goswami
Journal:  Mol Cell Biochem       Date:  2017-06-07       Impact factor: 3.396

3.  Influence of exercise on oxidative stress in patients with heart failure.

Authors:  Sabrina Weiss Sties; Leonardo Vidal Andreato; Tales de Carvalho; Ana Inês Gonzáles; Vitor Giatte Angarten; Anderson Zampier Ulbrich; Lourenço Sampaio de Mara; Almir Schmitt Netto; Edson Luiz da Silva; Alexandro Andrade
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

4.  G protein-coupled receptor kinase 2 modifies the cellular reaction to cisplatin through interactions with NADPH oxidase 4.

Authors:  Jane C Ammon; Danielle Valls; Mohamed Eldemerdash; Jigisha R Patel; Philip D Tran; Lifeng Feng; Michael Gi; Trang T Gonzalez; Chuc Phan; Ashley E Zendejas; Christopher H So
Journal:  Mol Cell Biochem       Date:  2021-01-04       Impact factor: 3.396

5.  β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway.

Authors:  Ming-Bing Xiao; Dan-Dan Jin; Yu-Jie Jiao; Wen-Kai Ni; Jin-Xia Liu; Li-Shuai Qu; Cui-Hua Lu; Run-Zhou Ni; Feng Jiang; Wei-Chang Chen
Journal:  Mol Biol Rep       Date:  2018-10-10       Impact factor: 2.316

Review 6.  Carcinogenesis and Reactive Oxygen Species Signaling: Interaction of the NADPH Oxidase NOX1-5 and Superoxide Dismutase 1-3 Signal Transduction Pathways.

Authors:  Alessia Parascandolo; Mikko O Laukkanen
Journal:  Antioxid Redox Signal       Date:  2018-11-22       Impact factor: 8.401

7.  G protein-coupled receptor kinase 2 modifies the ability of Caenorhabditis elegans to survive oxidative stress.

Authors:  Stacy A Henry; Selina Crivello; Tina M Nguyen; Magdalena Cybulska; Ngoc S Hoang; Mary Nguyen; Tajinder Badial; Nazgol Emami; Nasma Awada; Johnathen F Woodward; Christopher H So
Journal:  Cell Stress Chaperones       Date:  2020-10-16       Impact factor: 3.667

8.  G protein-coupled receptor kinase 5 modifies cancer cell resistance to paclitaxel.

Authors:  Joann Lagman; Paula Sayegh; Christina S Lee; Sarah M Sulon; Alec Z Jacinto; Vanessa Sok; Natalie Peng; Deniz Alp; Jeffrey L Benovic; Christopher H So
Journal:  Mol Cell Biochem       Date:  2019-07-30       Impact factor: 3.842

Review 9.  The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development.

Authors:  Jonathan Hullmann; Christopher J Traynham; Ryan C Coleman; Walter J Koch
Journal:  Pharmacol Res       Date:  2016-05-12       Impact factor: 7.658

Review 10.  Diagnostic, Prognostic, and Therapeutic Value of Circulating miRNAs in Heart Failure Patients Associated with Oxidative Stress.

Authors:  Md Sayed Ali Sheikh; Umme Salma; Baohai Zhang; Jimei Chen; Jian Zhuang; Zhu Ping
Journal:  Oxid Med Cell Longev       Date:  2016-06-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.